Once reconstituted with bacteriostatic water, refrigerate at 28C and use within approximately 14 days
Why GLP-1 drugs are changing weight loss Medications such as Ozempic and Wegovy (both forms of semaglutide), along with Mounjaro (tirzepatide), have rapidly transformed the conversation around obesity and weight loss
Processed meat intake and incidence of type 2 diabetes in younger and middle-aged women
Whilst the UK advises that women using GLP-1 receptor agonists should avoid pregnancy and use effective contraception, this advice is not being followed consistently in Australian clinical practice, says Associate Professor Grzeskowiak
Zepbound carries an FDA boxed warning for risk of thyroid C-cell tumors and is contraindicated in patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
Proc Am Assoc Cancer Res 38:137, 1997